WEBULL
WebtradeDownload

Koninklijke Philips (ENXTAM:PHIA) Launches AI Toothbrush As Undervalued Narrative Faces A Fresh Test

Simply Wall St · 1d ago

Koninklijke Philips (ENXTAM:PHIA) has put oral care back in focus after rolling out the Philips Sonicare Next-Generation DiamondClean 9900 Prestige, a toothbrush that leans heavily on third-generation AI and real-time brushing guidance.

The recent oral care launch comes after a mixed run for Koninklijke Philips, with the share price at €22.22 and short-term momentum improving. This is shown by a 1 month share price return of 5.11%, while the 1 year total shareholder return is slightly down 0.75% and the 5 year total shareholder return is down 30.02%. This points to long-term holders still sitting on sizeable losses, despite a 3 year total shareholder return of 37.56% that hints at some recovery from earlier weakness.

Scan how Philips' AI-driven oral care push compares with other health tech plays by reviewing our curated list of 126 healthcare AI stocks that blend medical focus with advanced data capabilities.

After that small rebound and a high profile AI toothbrush launch, the question now is simple: Does Koninklijke Philips still offer enough upside to justify the risks at €22.22?

Most Popular Narrative: 18% Undervalued

On the most followed view of Koninklijke Philips, the shares at €22.22 sit below an implied fair value of about €27.00. That gap hinges on steady growth in higher margin health tech and services rather than a quick rebound story.

Accelerating demand for hospital productivity and AI-enabled workflow solutions, including cloud-based Enterprise Informatics and monitoring platforms, is expected to support sustained mid-single-digit revenue growth and operating leverage as the mix of software and services increases, lifting group margins and earnings.

See why 10 investors see Koninklijke Philips as 18% undervalued.

Result: Fair Value of €26.99 (UNDERVALUED)

Still, there are clear stress points for the Koninklijke Philips story, including ongoing regulatory investigations and pressure on hospital capital budgets that could slow new equipment demand.

Find out about the key risks to this Koninklijke Philips narrative.

Next Steps

Koninklijke Philips presents mixed signals, including both risks and potential advantages. Consider acting promptly and evaluate the complete picture for yourself by reviewing the 4 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Koninklijke Philips?

If you want a clearer view of where to put fresh capital next, use the Simply Wall Street Screener to quickly compare opportunities that match your style and risk comfort.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.